Product Information
AMIODARONE HCL 400 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.7431 per EA under NDC 62135057830. Its NADAC has been published 115 times since Sep 11, 2024.
FDA first approved this application on Apr 8, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Chartwell RX LLCNDC
62135057830
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
11/18/2026
Active Ingredients
AMIODARONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077069FDA Approved
4/8/2005
TE Code
AB
On Market Since
1/1/2013
Pharmacological Classes
Price Statistics
The NADAC for AMIODARONE HCL 400 MG TABLET has been published 115 times since Sep 11, 2024, and over the history we have for it it has risen 235.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7431 per EA |
|---|---|
| All-time high | $0.7431 (Nov 18, 2026) |
| All-time low | $0.2214 (Sep 11, 2024) |
| 52-week high | $0.7431 |
| 52-week low | $0.3410 |
| Median price | $0.3926 |
| Average price | $0.4121 |
| Largest weekly change | +67.6% (Nov 20, 2024) |
| Weeks tracked | 115 |
| Tracking since | Sep 11, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amiodarone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMIODARONE HCL 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AMIODARONE HCL 400 MG TABLET, manufactured by Chartwell RX LLC, is $0.7431 per EA (NDC 62135057830), effective Nov 18, 2026.
How has the price of AMIODARONE HCL 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for AMIODARONE HCL 400 MG TABLET has risen 235.7%. It has been tracked across 115 weekly CMS publications since Sep 11, 2024.
What are the highest and lowest recorded NADAC prices for AMIODARONE HCL 400 MG TABLET?
Since Sep 11, 2024, the NADAC for AMIODARONE HCL 400 MG TABLET has ranged from a low of $0.2214 (Sep 11, 2024) to a high of $0.7431 (Nov 18, 2026), with a median of $0.3926 per EA.
Are there cheaper alternatives to AMIODARONE HCL 400 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PACERONE 400 MG TABLET, is $0.7188 per EA — about 3% below AMIODARONE HCL 400 MG TABLET.
Who manufactures AMIODARONE HCL 400 MG TABLET?
AMIODARONE HCL 400 MG TABLET (NDC 62135057830) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.